These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2573755)

  • 1. [Prescription of neuroleptics to mentally retarded patients is not directly criticized].
    Rasmussen P
    Lakartidningen; 1989 Nov; 86(46):3977. PubMed ID: 2573755
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior problems in adults with mental retardation. Psychopharmaceuticals are used too often--pedagogical efforts would be better].
    Näslund I
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1132-5. PubMed ID: 17472101
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neuroleptics in mentally retarded children].
    Höllge J
    Cesk Pediatr; 1993 Sep; 48(9):547-9. PubMed ID: 7902782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric illness in mental retardation: an update on pharmacotherapy.
    Masi G; Luccherino L
    Panminerva Med; 1997 Dec; 39(4):299-304. PubMed ID: 9478071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of neuroleptics given to the mentally retarded is not sufficiently proved].
    Beermann B; Thelander S
    Lakartidningen; 1989 Dec; 86(49):4320. PubMed ID: 2574763
    [No Abstract]   [Full Text] [Related]  

  • 8. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
    Olfson M; Blanco C; Liu L; Moreno C; Laje G
    Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Withdrawal of neuroleptics--a successful project at a nursing home for the mentally retarded].
    Näslund I
    Lakartidningen; 1992 Jun; 89(23):2084. PubMed ID: 1352838
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of risperidone among individuals with mental retardation: clinically supported or not?
    Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
    Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of prescription psychiatric drugs and religious service attendance.
    Harris KM; Larson S; Edlund MJ
    Psychiatr Serv; 2005 Apr; 56(4):396. PubMed ID: 15812085
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychopharmaceuticals and persons seeking asylum. Low prescription rate in refugee camps].
    Hartog R; Lilja J
    Lakartidningen; 1993 May; 90(21):2043-6. PubMed ID: 8502048
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacology in the mentally retarded and a few related issues.
    Gualtieri CT; Keppel JM
    Psychopharmacol Bull; 1985; 21(2):304-9. PubMed ID: 2860694
    [No Abstract]   [Full Text] [Related]  

  • 14. The dyskinesia Identification System Condensed User Scale (DISCUS): reliability, validity, and a total score cut-off for mentally ill and mentally retarded populations.
    Kalachnik JE; Sprague RL
    J Clin Psychol; 1993 Mar; 49(2):177-89. PubMed ID: 8098048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care.
    Verdoux H; Cougnard A; Grolleau S; Bégaud B
    Schizophr Res; 2005 Sep; 77(1):107-9. PubMed ID: 16005391
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuroleptics in psychogeriatrics. A proposal for a more rational prescription policy].
    Willekens-Bogaers MA; Vollaard EJ
    Tijdschr Gerontol Geriatr; 1985 Oct; 16(5):179-89. PubMed ID: 2867625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel program to facilitate monitoring physical health and adverse effects in children and adolescents prescribed antipsychotic medication.
    Ellis D; Shirzadi K; Grzeskowiak L; Angley M
    Australas Psychiatry; 2008 Oct; 16(5):368-9. PubMed ID: 18781460
    [No Abstract]   [Full Text] [Related]  

  • 19. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
    Simon EW; Blubaugh KM; Pippidis M
    Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacology of self-injurious behavior in the mentally retarded.
    Farber JM
    J Am Acad Child Adolesc Psychiatry; 1987 May; 26(3):296-302. PubMed ID: 2885304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.